Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Daiichi Sankyo
Express Scripts
Chubb
McKinsey
Covington
Accenture
Fuji

Generated: April 23, 2018

DrugPatentWatch Database Preview

HISTALOG Drug Profile

« Back to Dashboard

When do Histalog patents expire, and when can generic versions of Histalog launch?

Histalog is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HISTALOG is betazole hydrochloride. Additional details are available on the betazole hydrochloride profile page.
Drug patent expirations by year for HISTALOG
Medical Subject Heading (MeSH) Categories for HISTALOG
Synonyms for HISTALOG
[2-(1H-pyrazol-3-yl)ethyl]amine dihydrochloride
1009AJ
105-20-4
105-20-4 (Parent)
1121-45-5
138-92-1
138-92-1 (di-hydrochloride)
1C065P542O
1H-Pyrazole-3-ethanamine
1h-pyrazole-3-ethanamine dihydrochloride
1H-Pyrazole-3-ethanamine hydrochloride
1H-Pyrazole-3-ethanamine, dihydrochloride
1H-Pyrazole-3-ethanamine,dihydrochloride
2-(1H-Pyrazol-3-yl)-ethylamine
2-(1H-Pyrazol-3-yl)-ethylamine dihydrochloride
2-(1H-pyrazol-3-yl)ethan-1-amine
2-(1H-pyrazol-3-yl)ethan-1-amine dihydrochloride
2-(1H-Pyrazol-3-yl)ethanamine
2-(1H-Pyrazol-3-yl)ethanamine #
2-(1H-pyrazol-3-yl)ethanamine dihydrochloride
2-(1H-pyrazol-5-yl)ethan-1-amine
2-(1H-pyrazol-5-yl)ethanamine
2-(1H-pyrazol-5-yl)ethanamine dihydrochloride
2-(3-Pyrazolyl)ethanamine
2-(3-Pyrazolyl)ethanamine dihydrochloride
2-(3-Pyrazolyl)ethylamine
2-(3-Pyrazolyl)ethylamine dihydrochloride
3-(2-Aminoethyl)pyrazole
3-(2-Aminoethyl)pyrazole dihydrochloride
3-(beta-aminoethyl)pyrazole
3-Aminoethylpyrazole
3-beta-aminoethylpyrazole
3-beta-Aminoethylpyrazole dihydrochloride
3,5-b-pyrazoleethylamine dihydrochloride
3,5-beta-Pyrazoleethylamine dihydrochloride
4102AD
66ABP6C83F
AB00514680
AB60568
AC1L1PG3
AC1L27HO
AC1Q3AP0
AC1Q4WVG
AJ-07952
AK105476
AK311991
AKOS005362497
AKOS009209017
AKOS027321706
ALBB-018082
Ametazole
Ametazole dihydrochloride
API0009281
Betazol
Betazol [INN-Spanish]
Betazoldihydrochlorid
BETAZOLE
Betazole [INN]
Betazole dihydrochloride
Betazole HCl
Betazole hydrochloride
Betazole hydrochloride (JAN)
BETAZOLIUM CHLORIDE
Betazolo
Betazolo [DCIT]
Betazolum
Betazolum [INN-Latin]
BP-10560
BPBio1_000183
BSPBio_000165
C5H9N3.2HCl
CAS-138-92-1
CCG-220043
CHEBI:31280
CHEBI:59170
CHEMBL1200949
CHEMBL1201323
CTK0I1357
CTK8E3256
D01187
D01OUE
DB00272
DSSTox_CID_27769
DSSTox_GSID_47789
DSSTox_RID_82546
DTXSID6047789
DTXSID7022675
EINECS 203-278-3
EINECS 205-345-2
Gastramine
GTPL7126
HE039473
HE180298
Histalog (TN)
Histimin
HMS1568I07
JXDFEQONERDKSS-UHFFFAOYSA-N
KB-220235
KS-00000DRA
L000831
Lilly 96791
LS-128018
LS-171948
MCULE-6411210232
MFCD00867261
MFCD01693704
MLS002154183
MolPort-001-787-387
MolPort-006-110-972
MolPort-006-167-503
NCGC00016995-01
NCGC00016995-02
NCGC00016995-04
NSC-759872
NSC759872
Pharmakon1600-01503865
Prestwick-01E04
Prestwick0_000043
Prestwick1_000043
Prestwick2_000043
Prestwick3_000043
Pyrazole, 3-(2-aminoethyl)-
Pyrazole, 3-(2-aminoethyl)-, dihydrochloride
R4823
SCHEMBL1237742
SCHEMBL1237744
SCHEMBL157155
SMR001233474
SPBio_002086
Tox21_110729
Tox21_110729_1
TX-011567
UNII-1C065P542O
UNII-66ABP6C83F
Y-6432
ZINC1028
ZX-CM002485

US Patents and Regulatory Information for HISTALOG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HISTALOG betazole hydrochloride INJECTABLE;INJECTION 009344-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.